Haisco Pharmaceutical Group Co., Ltd.

This study tests a new drug called HSK47388 in 150 adults with moderate-to-severe ulcerative colitis, a chronic bowel disease. Participants will receive either the drug or a placebo to see if it reduces symptoms like diarrhea and bleeding. The goal is to find a safer, more effect…

This study tests an experimental drug called HSK42360 in children aged 6 to 17 with a certain type of brain tumor that has come back. The tumor must have a specific gene change called BRAF V600. The main goals are to find the safest dose and see how well the drug works at shrinki…

This early-stage study tests an experimental tablet, HSK47977, in adults whose Non-Hodgkin's lymphoma has returned or stopped responding to treatment. The main goals are to find the safest dose and check how well the drug works. About 110 participants will take part over roughly …

This early-stage study is testing an experimental oral drug called HSK42360-Na in adults with advanced solid tumors that have a specific BRAF V600 gene change. The main goals are to check the drug's safety, find the right dose, and see how the body processes it. About 159 partici…

This study tests an experimental tablet called HSK39297 in people with lupus nephritis, a kidney complication of lupus. About 105 adults will receive either the drug or a placebo daily for several months. The main goal is to see if the drug reduces protein in the urine, a sign of…

This study tests a new tablet called HSK39297 for people with IgA Nephropathy, a kidney disease. The goal is to see if it can lower protein in the urine and help protect kidney function over time. About 370 adults will take either the drug or a placebo for up to 104 weeks to chec…

This study tests a new medicine called HSK21542 for pain after hip replacement surgery. About 405 adults will get either HSK21542, morphine, or a placebo. The goal is to see if HSK21542 controls pain better and causes fewer side effects like nausea and vomiting.

This study looks at how the body processes a new drug called HSK39297 for paroxysmal nocturnal hemoglobinuria (PNH) in people with mild or moderate liver problems compared to those with healthy livers. Researchers will measure drug levels in the blood and check for side effects a…

This early-stage study is testing a new drug called HSK55879 in 46 healthy adults aged 18 to 45. The main goal is to see if the drug is safe and how the body processes it, including whether food changes its effects. Participants will be randomly assigned to receive the drug or a …